The study included 209 patients undergoing two-level cervical disc replacements, or cervical arthroplasty, with a Prestige LP, and 188 patients undergoing ACDF between June 2006 and November 2007.
Todd H. Lanman, MD, Matthew F. Gornet, MD, Jeffrey R. McConnell, MD, J. Kenneth Burkus, MD, Randall F. Dryer, MD, and Scott D. Hodges, DO, authored the study.
At 24 months, patients undergoing two-level cervical disc replacements saw a superior overall success rate (81.4 percent) compared to those undergoing ACDF (69.4 percent).
The researchers concluded two-level cervical disc replacement with a Prestige LP device proved equally effective and safe as ACDF for treating cervical disc degeneration disease at two adjacent disc levels at the 24-month postoperative follow-up.
More articles on spine:
Drs. Choll Kim, Peter Nora & more: 11 spine surgeons in this week’s headlines
Drs. Anthony Yeung, Jacob Buchowski & more: 4 spine surgeons & neurosurgeons recently receiving honors — April 7, 2017
ASA advocates for spinal injection coverage in Oregon — 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
